A little stress is good:: IFN-γ, demyelination, and multiple sclerosis

被引:46
|
作者
Lees, Jason R.
Cross, Anne H.
机构
[1] Washington Univ, Sch Med, Dept Neurol & Neurosurg, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA
来源
JOURNAL OF CLINICAL INVESTIGATION | 2007年 / 117卷 / 02期
关键词
D O I
10.1172/JCI31254
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The exact role(s) of the cytokine IFN-gamma in the demyelinating disease multiple sclerosis remain controversial, with evidence suggesting both detrimental and protective effects of the cytokine in MS and MS models such as EAE. The study by Lin and coworkers in this issue of the JCI produces evidence that protective effects of IFN-gamma on mature oligodendrocytes during EAE induction are mediated via activation of the pancreatic ER kinase (PERK), resulting in induction of the endoplasmic reticular stress response pathway (see the related article beginning on page 448). Modulation of this stress pathway has what we believe to be novel therapeutic potential for MS.
引用
收藏
页码:297 / 299
页数:3
相关论文
共 50 条
  • [1] IFN-β pharmacogenomics in multiple sclerosis
    Vandenbroeck, Koen
    Urcelay, Elena
    Comabella, Manuel
    PHARMACOGENOMICS, 2010, 11 (08) : 1137 - 1148
  • [2] Neutralising antibodies to IFN-β in patients with multiple sclerosis
    Bagnato, Francesca
    Riva, Marco
    Antonelli, Guido
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2006, 6 (08) : 773 - 785
  • [3] Genomic effects of IFN-β in multiple sclerosis patients
    Weinstock-Guttman, B
    Badgett, D
    Patrick, K
    Hartrich, L
    Santos, R
    Hall, D
    Baier, M
    Feichter, J
    Ramanathan, M
    JOURNAL OF IMMUNOLOGY, 2003, 171 (05): : 2694 - 2702
  • [4] Defining and scoring response to IFN-β in multiple sclerosis
    Maria Pia Sormani
    Nicola De Stefano
    Nature Reviews Neurology, 2013, 9 : 504 - 512
  • [5] Defining and scoring response to IFN-β in multiple sclerosis
    Sormani, Maria Pia
    De Stefano, Nicola
    NATURE REVIEWS NEUROLOGY, 2013, 9 (09) : 504 - 512
  • [6] Biological monitoring of IFN-β therapy in Multiple Sclerosis
    Bertolotto, A.
    Granieri, L.
    Marnetto, F.
    Valentino, P.
    Sala, A.
    Capobianco, M.
    Malucchi, S.
    Di Sapio, A.
    Malentacchi, M.
    Matta, M.
    Caldano, M.
    CYTOKINE & GROWTH FACTOR REVIEWS, 2015, 26 (02) : 241 - 248
  • [7] Demyelination during multiple sclerosis is associated with combined activation of microglia/macrophages by IFN-γ and alpha B-crystallin
    Bsibsi, Malika
    Peferoen, Laura A. N.
    Holtman, Inge R.
    Nacken, Peter J.
    Gerritsen, Wouter H.
    Witte, Maarten E.
    van Horssen, Jack
    Eggen, Bart J. L.
    van der Valk, Paul
    Amor, Sandra
    van Noort, Johannes M.
    ACTA NEUROPATHOLOGICA, 2014, 128 (02) : 215 - 229
  • [8] Demyelination during multiple sclerosis is associated with combined activation of microglia/macrophages by IFN-γ and alpha B-crystallin
    Malika Bsibsi
    Laura A. N. Peferoen
    Inge R. Holtman
    Peter J. Nacken
    Wouter H. Gerritsen
    Maarten E. Witte
    Jack van Horssen
    Bart J. L. Eggen
    Paul van der Valk
    Sandra Amor
    Johannes M. van Noort
    Acta Neuropathologica, 2014, 128 : 215 - 229
  • [9] Neutralizing antibodies against IFN-β in multiple sclerosis:: antagonization of IFN-β mediated suppression of MMPs
    Gilli, F
    Bertolotto, A
    Sala, A
    Hoffmann, F
    Capobianco, M
    Malucchi, S
    Glass, T
    Kappos, L
    Lindberg, RLP
    Leppert, D
    BRAIN, 2004, 127 : 259 - 268
  • [10] The effect of IFN-β on black holes in patients with multiple sclerosis
    Bagnato, Francesca
    Evangelou, Iordanis E.
    Gallo, Antonio
    Gaindh, Deeya
    Yao, Karen
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (07) : 1079 - 1091